What to Know About mRNA Vaccines

Health Secretary Robert F. Kennedy Jr. has repeatedly questioned the safety of mRNA vaccines against Covid-19. Scientists with funding from the National Institutes of Health were advised to scrub their grants of any reference to mRNA. Around the country, state legislatures are considering bills to ban or limit such vaccines, with one describing them as […]

Saubio's Promo Tools
Continue Reading


Suddenly, It Looks Like We’re in a Golden Age for Medicine

Ozempic and Wegovy have already changed the landscape for obesity in America — a breakthrough that has been described and debated so much in terms of cosmetic benefits and medical moral hazard that it can be easy to forget that obesity is among the largest risk factors for preventable death in the United States. Next-generation […]

Saubio's Promo Tools
Continue Reading


Most of the World’s Vaccines Likely Won’t Prevent Infection From Omicron

A growing body of preliminary research suggests the Covid vaccines used in most of the world offer almost no defense against becoming infected by the highly contagious Omicron variant. All vaccines still seem to provide a significant degree of protection against serious illness from Omicron, which is the most crucial goal. But only the Pfizer […]

Saubio's Promo Tools
Continue Reading
Priority SubmissionsPriority Search Engine Submissions
48 Hour Inclusion to all major search engines and web directories with PrioritySubmit.com!

First, Impressive Vaccines for Covid. Next Up: The Flu.

As the world grapples with Covid-19, influenza isn’t getting much attention these days. But the flu’s global impact is staggering: three million to five million cases of severe illness every year, and up to 650,000 deaths. Every few decades, a new flu strain spills over from animals and leads to a pandemic. The deadly toll […]

Saubio's Promo Tools
Continue Reading
Priority SubmissionsPriority Search Engine Submissions
48 Hour Inclusion to all major search engines and web directories with PrioritySubmit.com!

CureVac’s Covid-19 Vaccine Disappoints in Clinical Trial

The German company CureVac delivered disappointing preliminary results on Wednesday from a clinical trial of its Covid-19 vaccine, dimming hopes that it could help fill the world’s great need. The trial, which included 40,000 volunteers in Latin America and Europe, estimated that CureVac’s mRNA vaccine had an efficacy of just 47 percent, among the lowest […]

Saubio's Promo Tools
Continue Reading